Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Some think investing in stocks requires substantial start-up capital, but that's false. Even with a modest sum, like $40, ...

The Graduate Aptitude Test-Biotechnology (GAT-B) 2025 application period is now open at exams.nta.ac.in/DBT, according to the ...

TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia. See ...

Sanofi has removed a clutch of programs from its clinical pipeline, scratching out entries for its late-phase BTK inhibitor and phase 1 prospects linked to the multibillion-dollar takeovers of Ablynx, ...

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of ...

The Wuhan company didn’t bother with the dark web. It spruiked its goods right in the open, showing mounds of white powder ...

In other instances, recombinant forms of certain therapeutic ... there were 369 biotechnology medicines in development in the US 3. Of these, almost half (175) were aimed at treating cancer ...

Funding Aimed at Accelerating Rollout of Decentralized CGT Platform GERMANTOWN, MD / ACCESS Newswire / January 28, 2025 / Orgenesis Inc. (OTCQX:ORGS) ("Orgenesis" or the "Company"), a global biotech c ...